These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26122847)

  • 1. CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling.
    Moutal A; Honnorat J; Massoma P; Désormeaux P; Bertrand C; Malleval C; Watrin C; Chounlamountri N; Mayeur ME; Besançon R; Naudet N; Magadoux L; Khanna R; Ducray F; Meyronet D; Thomasset N
    Cancer Res; 2015 Sep; 75(17):3519-28. PubMed ID: 26122847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of RND3/RhoE in glioblastoma patients promotes tumorigenesis through augmentation of notch transcriptional complex activity.
    Liu B; Lin X; Yang X; Dong H; Yue X; Andrade KC; Guo Z; Yang J; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Chen Q; Mao S; Chen Q; Chang J
    Cancer Med; 2015 Sep; 4(9):1404-16. PubMed ID: 26108681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells.
    Zhu TS; Costello MA; Talsma CE; Flack CG; Crowley JG; Hamm LL; He X; Hervey-Jumper SL; Heth JA; Muraszko KM; DiMeco F; Vescovi AL; Fan X
    Cancer Res; 2011 Sep; 71(18):6061-72. PubMed ID: 21788346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk.
    Sun T; Patil R; Galstyan A; Klymyshyn D; Ding H; Chesnokova A; Cavenee WK; Furnari FB; Ljubimov VA; Shatalova ES; Wagner S; Li D; Mamelak AN; Bannykh SI; Patil CG; Rudnick JD; Hu J; Grodzinski ZB; Rekechenetskiy A; Falahatian V; Lyubimov AV; Chen YL; Leoh LS; Daniels-Wells TR; Penichet ML; Holler E; Ljubimov AV; Black KL; Ljubimova JY
    Cancer Res; 2019 Mar; 79(6):1239-1251. PubMed ID: 30659021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined gene signature of hypoxia and notch pathway in human glioblastoma and its prognostic relevance.
    Irshad K; Mohapatra SK; Srivastava C; Garg H; Mishra S; Dikshit B; Sarkar C; Gupta D; Chandra PS; Chattopadhyay P; Sinha S; Chosdol K
    PLoS One; 2015; 10(3):e0118201. PubMed ID: 25734817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. POFUT1 acts as a tumor promoter in glioblastoma by enhancing the activation of Notch signaling.
    Li Q; Wang J; Ma X; Wang M; Zhou L
    J Bioenerg Biomembr; 2021 Oct; 53(5):621-632. PubMed ID: 34251584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature.
    Kristoffersen K; Nedergaard MK; Villingshøj M; Borup R; Broholm H; Kjær A; Poulsen HS; Stockhausen MT
    Cancer Biol Ther; 2014 Jul; 15(7):862-77. PubMed ID: 24755988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deltex-1 activates mitotic signaling and proliferation and increases the clonogenic and invasive potential of U373 and LN18 glioblastoma cells and correlates with patient survival.
    Huber RM; Rajski M; Sivasankaran B; Moncayo G; Hemmings BA; Merlo A
    PLoS One; 2013; 8(2):e57793. PubMed ID: 23451269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norrin mediates tumor-promoting and -suppressive effects in glioblastoma via Notch and Wnt.
    El-Sehemy A; Selvadurai H; Ortin-Martinez A; Pokrajac N; Mamatjan Y; Tachibana N; Rowland K; Lee L; Park N; Aldape K; Dirks P; Wallace VA
    J Clin Invest; 2020 Jun; 130(6):3069-3086. PubMed ID: 32182224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch signaling enhances nestin expression in gliomas.
    Shih AH; Holland EC
    Neoplasia; 2006 Dec; 8(12):1072-82. PubMed ID: 17217625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a new CRMP5 isoform present in the nucleus of cancer cells and enhancing their proliferation.
    Brot S; Malleval C; Benetollo C; Auger C; Meyronet D; Rogemond V; Honnorat J; Moradi-Améli M
    Exp Cell Res; 2013 Mar; 319(5):588-99. PubMed ID: 23298946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness.
    Ylivinkka I; Sihto H; Tynninen O; Hu Y; Laakso A; Kivisaari R; Laakkonen P; Keski-Oja J; Hyytiäinen M
    J Exp Clin Cancer Res; 2017 Jan; 36(1):9. PubMed ID: 28069038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Farnesyltransferase Potentiates NOTCH-Targeted Therapy against Glioblastoma Stem Cells.
    Ma Y; Cheng Z; Liu J; Torre-Healy L; Lathia JD; Nakano I; Guo Y; Thompson RC; Freeman ML; Wang J
    Stem Cell Reports; 2017 Dec; 9(6):1948-1960. PubMed ID: 29198824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notch- and vitamin D signaling in 1,25(OH)2D3-resistant glioblastoma multiforme (GBM) cell lines.
    Reichrath S; Müller CS; Gleissner B; Pfreundschuh M; Vogt T; Reichrath J
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):420-4. PubMed ID: 20206691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of Notch signaling activation to human glioblastoma multiforme.
    Kanamori M; Kawaguchi T; Nigro JM; Feuerstein BG; Berger MS; Miele L; Pieper RO
    J Neurosurg; 2007 Mar; 106(3):417-27. PubMed ID: 17367064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNER, an epigenetically modulated gene, regulates glioblastoma-derived neurosphere cell differentiation and tumor propagation.
    Sun P; Xia S; Lal B; Eberhart CG; Quinones-Hinojosa A; Maciaczyk J; Matsui W; Dimeco F; Piccirillo SM; Vescovi AL; Laterra J
    Stem Cells; 2009 Jul; 27(7):1473-86. PubMed ID: 19544453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
    Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A
    J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis.
    Tian R; Wang J; Yan H; Wu J; Xu Q; Zhan X; Gui Z; Ding M; He J
    Oncogene; 2017 Oct; 36(42):5861-5873. PubMed ID: 28628119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial transcriptome analysis reveals Notch pathway-associated prognostic markers in IDH1 wild-type glioblastoma involving the subventricular zone.
    Jungk C; Mock A; Exner J; Geisenberger C; Warta R; Capper D; Abdollahi A; Friauf S; Lahrmann B; Grabe N; Beckhove P; von Deimling A; Unterberg A; Herold-Mende C
    BMC Med; 2016 Oct; 14(1):170. PubMed ID: 27782828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism.
    Phillips E; Lang V; Bohlen J; Bethke F; Puccio L; Tichy D; Herold-Mende C; Hielscher T; Lichter P; Goidts V
    Int J Cancer; 2016 Oct; 139(8):1776-87. PubMed ID: 27299852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.